Treatment of cardiac manifestations in Fabry disease with the oral drug Migalastat: First 12 months results from a cohort of amenable all-comers

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Cardiomyopathy in Fabry disease Infiltrative Myocardial Disease ESC Premium Access ESC Congress 2018

ESC 365 is supported by

ESC 365 is supported by